Skip to content

Correlation between serum ASGR1, CtBP2, LPCAT3 and TRAF5 levels and type 2 diabetes

Correlation between serum ASGR1, CtBP2, LPCAT3 and TRAF5 levels and type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086076
Enrollment
Unknown
Registered
2024-06-25
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

group consisting of patients with type 2 diabetes:none
control group:none

Sponsors

Taizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 18 to 80 years old. 2. Case group: patients with newly diagnosed type 2 diabetes; Control group: Individuals with normal glucose tolerance.

Exclusion criteria

Exclusion criteria: 1. The subjects are under 18 years old or over 80 years old. 2. Diagnosed as type 1 diabetes or other types of diabetes. 3. Has received regular hypoglycemic therapy; 4. Severe liver and kidney dysfunction, cancer. 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
asialoglycoprotein receptor 1;Carboxyl terminal binding protein 2;Hemolytic phospholipid acyltransferase 3; TNF receptor associated factor 5;

Countries

China

Contacts

Public ContactHaifeng Zhu

Taizhou People's Hospital

zhf20175232016@163.com+86 189 9466 3138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026